Scandinavian Medical Solutions A/S

SMSMED.CO's capital structure is characterized by a debt-to-equity ratio of 0.77, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.56, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess. However, the company's operating cash flow is negative at -13.41 million DKK, and free cash flow is also negative at -12.06 million DKK, indicating a cash outflow from operations. This is further exacerbated by a capital expenditure of -20.81 million DKK, which suggests the company is investing in long-term assets but is not generating enough cash to support these investments.

In terms of profitability, SMSMED.CO's return on equity is 0.03%, and return on assets is 0.01%, both of which are significantly below the industry median for the Advanced Medical Equipment & Technology sector. The company's net income is minimal at 26,000 DKK, and its operating income is only 1.79 million DKK, indicating that the company is not generating substantial profits relative to its revenue of 245.44 million DKK. The gross profit margin is 23.11%, which is a key metric for the industry, but it is not clear how this compares to the industry median.

SMSMED.CO's revenue is concentrated in a single business segment, as there are no disclosed segments in the financial data. The company's geographic exposure is not specified, but the financial data is reported in Danish kroner, suggesting a primary market in Denmark. There is no information on revenue concentration by region or customer, which limits the understanding of the company's geographic diversification.

The company's growth trajectory is not clearly defined, as there is no outlook data provided for the current or next fiscal year. The company's revenue history shows a single data point, making it difficult to assess trends or growth rates. The lack of analyst estimates for revenue growth further complicates the assessment of the company's future performance.

SMSMED.CO faces several risk factors, including a medium liquidity risk due to its negative operating and free cash flows. The company's dilution risk is assessed as low, with no significant dilution potential reported. However, the company's net cash position is negative after subtracting total debt, which could indicate financial stress. There are no specific dilution sources mentioned, but the company's capital structure and cash flow issues could lead to future dilution if not addressed.

Recent events and filings for SMSMED.CO are not detailed in the provided data. The company's financial performance and risk profile suggest that it may need to address its cash flow and profitability issues to sustain its operations and growth. The lack of analyst recommendations and the uniform price target of 3.00 DKK indicate a cautious outlook from the market.